73 related articles for article (PubMed ID: 22483089)
21. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
[TBL] [Abstract][Full Text] [Related]
22. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
23. Thiazole analog as stearoyl-CoA desaturase 1 inhibitor.
Li CS; Belair L; Guay J; Murgasva R; Sturkenboom W; Ramtohul YK; Zhang L; Huang Z
Bioorg Med Chem Lett; 2009 Sep; 19(17):5214-7. PubMed ID: 19632834
[TBL] [Abstract][Full Text] [Related]
24. Platycodon grandiflorum modifies adipokines and the glucose uptake in high-fat diet in mice and L6 muscle cells.
Ahn YM; Kim SK; Kang JS; Lee BC
J Pharm Pharmacol; 2012 May; 64(5):697-704. PubMed ID: 22471365
[TBL] [Abstract][Full Text] [Related]
25. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
26. Cortex Lycii Radicis extracts improve insulin resistance and lipid metabolism in obese-diabetic rats.
Ye Z; Huang Q; Ni HX; Wang D
Phytother Res; 2008 Dec; 22(12):1665-70. PubMed ID: 19003954
[TBL] [Abstract][Full Text] [Related]
27. SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors.
Ramtohul YK; Black C; Chan CC; Crane S; Guay J; Guiral S; Huang Z; Oballa R; Xu LJ; Zhang L; Li CS
Bioorg Med Chem Lett; 2010 Mar; 20(5):1593-7. PubMed ID: 20137926
[TBL] [Abstract][Full Text] [Related]
28. Antidiabetic and antiobesity effects of Ampkinone (6f), a novel small molecule activator of AMP-activated protein kinase.
Oh S; Kim SJ; Hwang JH; Lee HY; Ryu MJ; Park J; Kim SJ; Jo YS; Kim YK; Lee CH; Kweon KR; Shong M; Park SB
J Med Chem; 2010 Oct; 53(20):7405-13. PubMed ID: 20873794
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and evaluation of some novel dibenzo[b,d]furan carboxylic acids as potential anti-diabetic agents.
Lakshminarayana N; Prasad YR; Gharat L; Thomas A; Narayanan S; Raghuram A; Srinivasan CV; Gopalan B
Eur J Med Chem; 2010 Sep; 45(9):3709-18. PubMed ID: 20627471
[TBL] [Abstract][Full Text] [Related]
30. Novel euglycemic and hypolipidemic agents: Part-2. Antioxidant moiety as structural motif.
Reddy KA; Lohray BB; Bhushan V; Reddy AS; Kishore PH; Rao VV; Saibaba V; Bajji AC; Rajesh BM; Reddy KV; Chakrabarti R; Rajagopalan R
Bioorg Med Chem Lett; 1998 May; 8(9):999-1002. PubMed ID: 9871696
[TBL] [Abstract][Full Text] [Related]
31. Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.
Patch RJ; Searle LL; Kim AJ; De D; Zhu X; Askari HB; O'Neill JC; Abad MC; Rentzeperis D; Liu J; Kemmerer M; Lin L; Kasturi J; Geisler JG; Lenhard JM; Player MR; Gaul MD
J Med Chem; 2011 Feb; 54(3):788-808. PubMed ID: 21218783
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and pharmacological evaluation of 2-(4-sulfonylphenyl)-2-[(E)-pyrrolidin-1-ylimino]-N-thiazoleacetamides as glucokinase activators.
Sugama H; Matsudaira T; Yanagisawa H; Ohashi R; Nawano M; Yasuda K; Takayama H
Bioorg Med Chem Lett; 2020 Aug; 30(15):127249. PubMed ID: 32527453
[TBL] [Abstract][Full Text] [Related]
33. Investigation of the influence of vanadium compounds treatment in NZO mice model--preliminary study.
Krośniak M; Francik R; Kołodziejczyk K; Wojtanowska-Krośniak A; Tedeschi C; Petrone V; Gryboś R
Acta Pol Pharm; 2014; 71(2):271-8. PubMed ID: 25275165
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological activity of phenoxyacetic acid derivatives as novel free fatty acid receptor 1 agonists.
Li Z; Wang X; Xu X; Yang J; Xia W; Zhou X; Huang W; Qian H
Bioorg Med Chem; 2015 Nov; 23(22):7158-64. PubMed ID: 26482570
[TBL] [Abstract][Full Text] [Related]
35. Oral hypoglycemic agents. Pyrimido[1,2-a]indoles and related compounds.
Cliffe IA; Lien EL; Mansell HL; Steiner KE; Todd RS; White AC; Black RM
J Med Chem; 1992 Apr; 35(7):1169-75. PubMed ID: 1560431
[TBL] [Abstract][Full Text] [Related]
36. Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.
Ellinboe JW; Alessi TR; Dolak TM; Nguyen TT; Tomer JD; Guzzo F; Bagli JF; McCaleb ML
J Med Chem; 1992 Apr; 35(7):1176-83. PubMed ID: 1560432
[TBL] [Abstract][Full Text] [Related]
37. Novel thieno oxazine analogues as antihyperglycemic and lipid modulating agents.
Das SK; Reddy KA; Abbineni C; Iqbal J; Suresh J; Premkumar M; Chakrabarti R
Bioorg Med Chem Lett; 2003 Feb; 13(3):399-403. PubMed ID: 12565938
[TBL] [Abstract][Full Text] [Related]
38. 3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
Sheppard GS; Pireh D; Carrera GM; Bures MG; Heyman HR; Steinman DH; Davidsen SK; Phillips JG; Guinn DE; May PD
J Med Chem; 1994 Jun; 37(13):2011-32. PubMed ID: 8027984
[TBL] [Abstract][Full Text] [Related]
39. Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effects.
Alexiou P; Papakyriakou A; Ntougkos E; Papaneophytou CP; Liepouri F; Mettou A; Katsoulis I; Maranti A; Tsiliouka K; Strongilos A; Chaitidou S; Douni E; Kontopidis G; Kollias G; Couladouros E; Eliopoulos E
Arch Pharm (Weinheim); 2014 Nov; 347(11):798-805. PubMed ID: 25160057
[TBL] [Abstract][Full Text] [Related]
40. Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity.
Varshney K; Gupta AK; Sonkar R; Varshney S; Mishra A; Bhatia G; Gaikwad A; Srivastava AK; Saxena M; Jain S; Saxena AK
Curr Top Med Chem; 2018; 18(26):2256-2265. PubMed ID: 30569857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
